Join BNMS | Print Page | Contact Us | Sign In
Radiopharmaceutical Defects Reporting

Sometimes product defects are noticed on preparation or quality control testing of radiopharmaceuticals or unusual biodistribution may be noted during scanning of patients. Although product defects are rare, it is still important to record any defects or unusual biodistribution observed. This is to enable us to keep comprehensive information and to help identify trends that may impact patient care or safety.

The UK Radiopharmacy Group act as coordinator for the collation of data relating to defective radiopharmaceutical products and patient adverse reactions.  This data is carefully scrutinised and acts as a means of informing the UK Nuclear Medicine community of potentially serious defects in products as well as a compendium of drug interactions and reactions which are published on an annual basis in the European Journal of Nuclear Medicine and Molecular Imaging.

I have read the Privacy Policy and grant consent to use my data.


















Once you have submitted your form, you will be able to print your submission on the next page for your records

 

 

© 2013 BNMS unless otherwise stated.
The BNMS is a registered as a company in England and Wales with number 08082786.  The BNMS is a charity governed by the rules of the Charity Commission for England and Wales - Registered Number 1150234.  Registered Office: The Royal College of Physicians, 11 St. Andrew's Place, Regent's Park, London NW1 4LE.
The British Nuclear Medicine Society is not able to give specific clinical advice to members of the public. If you are concerned about your scan or therapy please seek the opinion of a nuclear medicine clinician where you were seen or the clinician who referred you to the department or your GP.
Enquiries related to issues such as internships and work experience opportunities, should be directed to the relevant professional body e.g., for radiologists, this will be the Royal College of Radiologists.